This study is looking at ways to improve telemedicine care for adults with Type 2 Diabetes (T2D) who use insulin and have other health conditions. Researchers want to see if an "Enhanced Telemedicine for Type 2 Diabetes" approach, which includes support from a team of diabetes specialists, is more practical and helpful than "Usual Telemedicine Endocrinology Care for T2D." You might be able to join if you are an adult between 18 and 80 years old with T2D, an HbA1c (a measure of blood sugar over time) of 8% or higher, and access to a smartphone, tablet, or computer for video visits. The study aims to enroll 50 participants and will measure how many people join and how many stay in the study over 6 to 12 months. The current recruitment status is unclear.

Study design

This study will involve 50 participants who will be randomly assigned to either the enhanced telemedicine group or the usual telemedicine group. It is a pilot study to test the feasibility of the intervention.

What's involved

You would have 2-3 telemedicine diabetes care visits over about 6 months and complete surveys with each visit.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for 6 months to assess loss to follow-up, and recruitment will be measured at 12 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.